Long-defined by high prices, shortages and weekly injections, weight loss drugs including Wegovy and Zepbound are expected to ...

Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and ...

Eateries are adapting menus to cater to weight loss drug users who don’t feel like making their own meals.

Meanwhile, in attempts to address long-standing thyroid cancer concerns, a research team conducted a 350,000-person analysis ...

Madrigal’s Rezdiffra tops $1B run-rate in MASH, but losses and rising GLP-1/FGF21 competition may cap upside into 2026. See ...

By: Pete Grieve Americans have become so accustomed to price increases year after year that the idea of anything’s cost going ...

The gray-market drugs flooding Silicon Valley reveal a community that believes it can move faster than the F.D.A.

In 2026, weight loss medications like Wegovy injections will become more affordable thanks to a new self-pay platform, while ...

Drug companies in Canada are allowed to make lower priced generic versions of the blockbuster drug Ozempic as of next week, ...

Hone Health reports that GLP-1 medications are increasingly prescribed for weight loss and metabolic health, even in those ...

In many ways, 2025 was a banner year for chronic disease. America’s enduring ailments became a central theme of the Trump ...

DEAR DR. ROACH: I am a 75-year-old man with an elevated A1C level; I was diagnosed with prediabetes. I feel healthy but have ...